Yin J, Bo W, Sun J, Xiang X, Lang J, Zhong J
J Clin Transl Hepatol. 2017; 5(2):169-176.
PMID: 28660155
PMC: 5472938.
DOI: 10.14218/JCTH.2016.00071.
Jiang J, Lao Y, Yuan B, Yin J, Liu X, Chen L
Oncotarget. 2017; 8(20):33911-33921.
PMID: 28430610
PMC: 5464922.
DOI: 10.18632/oncotarget.15411.
Katagiri S, Yamamoto M
Surg Today. 2013; 44(2):219-26.
PMID: 23591833
PMC: 3898334.
DOI: 10.1007/s00595-013-0585-6.
Samuel M, Chow P, Shih-Yen E, Machin D, Soo K
Cochrane Database Syst Rev. 2009; (1):CD001199.
PMID: 19160192
PMC: 7096780.
DOI: 10.1002/14651858.CD001199.pub2.
Nagano Y, Tanaka K, Togo S, Matsuo K, Kunisaki C, Sugita M
World J Surg. 2004; 29(1):66-71.
PMID: 15599739
DOI: 10.1007/s00268-004-7509-y.
Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.
Feldman E, Wu P, Beresneva T, Helsabeck C, Rodriguez M, Bartlett D
J Gastrointest Surg. 2004; 8(2):200-7.
PMID: 15036196
DOI: 10.1016/j.gassur.2003.11.005.
Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.
Mabed M, El-Helw L, Shamaa S
Br J Cancer. 2004; 90(1):65-9.
PMID: 14710208
PMC: 2395314.
DOI: 10.1038/sj.bjc.6601463.
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.
Poon R, Fan S, Lo C, Ng I, Liu C, Lam C
Ann Surg. 2001; 234(1):63-70.
PMID: 11420484
PMC: 1421949.
DOI: 10.1097/00000658-200107000-00010.
Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma.
Lau W, Leung T, Lai B, Liew C, Ho S, Yu S
Ann Surg. 2001; 233(2):236-41.
PMID: 11176130
PMC: 1421206.
DOI: 10.1097/00000658-200102000-00013.
Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma.
Lo C, Lai E, Liu C, Fan S, Wong J
Ann Surg. 1998; 227(4):527-32.
PMID: 9563541
PMC: 1191308.
DOI: 10.1097/00000658-199804000-00013.
Hepatocellular carcinoma: prospective assessments of the T-factor with CT, US, and MR imaging.
Honda H, Onitsuka H, Adachi E, Ochiai K, Gibo M, Yasumori K
Abdom Imaging. 1993; 18(3):247-52.
PMID: 8389629
DOI: 10.1007/BF00198115.
Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years.
Nagasue N, Kohno H, Chang Y, Taniura H, Yamanoi A, Uchida M
Ann Surg. 1993; 217(4):375-84.
PMID: 8385442
PMC: 1242804.
DOI: 10.1097/00000658-199304000-00009.
A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use.
Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E
Ann Surg. 1994; 219(4):342-6.
PMID: 8161258
PMC: 1243149.
DOI: 10.1097/00000658-199404000-00003.
Role of surgical treatment for recurrent hepatocellular carcinoma after hepatic resection.
Nakajima Y, Ohmura T, Kimura J, Shimamura T, Misawa K, Matsushita M
World J Surg. 1993; 17(6):792-5.
PMID: 8109120
DOI: 10.1007/BF01659099.
[Liver resections for primary liver malignancies. Personal results and analysis of the literature].
Zieren J, Zieren H, Muller J
Langenbecks Arch Chir. 1994; 379(3):159-67.
PMID: 8052057
DOI: 10.1007/BF00680112.
En bloc resection for extensive hepatocellular carcinoma: is it advisable?.
Jeng K, Chen B, Lin H
World J Surg. 1994; 18(6):834-9.
PMID: 7846905
DOI: 10.1007/BF00299079.
Therapeutic modalities and prognostic factors for primary and secondary liver tumors.
Lehnert T, Otto G, Herfarth C
World J Surg. 1995; 19(2):252-63.
PMID: 7754632
DOI: 10.1007/BF00308635.
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients.
Lai E, Fan S, Lo C, Chu K, Liu C, Wong J
Ann Surg. 1995; 221(3):291-8.
PMID: 7717783
PMC: 1234572.
DOI: 10.1097/00000658-199503000-00012.
Experience with 150 liver resections.
Iwatsuki S, Shaw Jr B, Starzl T
Ann Surg. 1983; 197(3):247-53.
PMID: 6830332
PMC: 1352725.
DOI: 10.1097/00000658-198303000-00001.
Hepatic resection for primary liver malignancy.
KINAMI Y, Shinmura K, Miyazaki I
Jpn J Surg. 1984; 14(6):486-93.
PMID: 6099450
DOI: 10.1007/BF02469791.
